Stocks moved higher on the easing of pandemic restrictions, led by battered sectors such as energy, financial and industrial groups.
The S&P 500 was up 1.2% to 3,116.78 during midday trading.
The Dow Jones Industrial Average rose 1.6% to 26,165.70.
The Nasdaq rose 0.7% to 9,676.97.
The yield on a 10-year Treasury bond jumped 12% to 0.762%.
The price of gold fell 1.8% to $1,703.
The price for a barrel of oil was flat at $36.78.
REAL ESTATE
Healthpeak Properties Inc. (NYSE: PEAK) climbed 4.1% to $27.14 and a $14.6 billion market cap. Volume was about half of its daily average of 5.4 million. Shares of the Irvine-based real estate investor in health-related properties are still off about 30% since late February.
MEDICAL DEVICE MAKERS
Glaukos Corp. (NYSE: GKOS) rose 8.4% to $44.66 and a $2 billion market cap. Share volume of the San Clemente based maker of eye stents was about a third of its daily average of 968,000.
Urovant Sciences Ltd. (Nasdaq: UROV) jumped 11% to $11.83 and a $361 million market cap. The Irvine-based maker of products to treat overactive bladders yesterday named Walt Johnston as senior vice president of commercial and Kenton Stewart as senior vice president of market access. Previously Johnston was senior vice president of the Urology and Hospital Business Unit at Astellas Pharma Inc. and Stewart was the leader of the Health Systems Business Unit at Alkermes.
